Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2011 1
2012 4
2013 3
2015 2
2016 6
2017 4
2018 5
2019 2
2020 3
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

30 results
Results by year
Filters applied: . Clear all
Page 1
Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade.
Hsu J, Hodgins JJ, Marathe M, Nicolai CJ, Bourgeois-Daigneault MC, Trevino TN, Azimi CS, Scheer AK, Randolph HE, Thompson TW, Zhang L, Iannello A, Mathur N, Jardine KE, Kirn GA, Bell JC, McBurney MW, Raulet DH, Ardolino M. Hsu J, et al. Among authors: bourgeois daigneault mc. J Clin Invest. 2018 Oct 1;128(10):4654-4668. doi: 10.1172/JCI99317. Epub 2018 Sep 10. J Clin Invest. 2018. PMID: 30198904 Free PMC article.
Methionine Metabolism Shapes T Helper Cell Responses through Regulation of Epigenetic Reprogramming.
Roy DG, Chen J, Mamane V, Ma EH, Muhire BM, Sheldon RD, Shorstova T, Koning R, Johnson RM, Esaulova E, Williams KS, Hayes S, Steadman M, Samborska B, Swain A, Daigneault A, Chubukov V, Roddy TP, Foulkes W, Pospisilik JA, Bourgeois-Daigneault MC, Artyomov MN, Witcher M, Krawczyk CM, Larochelle C, Jones RG. Roy DG, et al. Among authors: bourgeois daigneault mc. Cell Metab. 2020 Feb 4;31(2):250-266.e9. doi: 10.1016/j.cmet.2020.01.006. Cell Metab. 2020. PMID: 32023446 Free article.
The pros and cons of interferons for oncolytic virotherapy.
Geoffroy K, Bourgeois-Daigneault MC. Geoffroy K, et al. Among authors: bourgeois daigneault mc. Cytokine Growth Factor Rev. 2020 Dec;56:49-58. doi: 10.1016/j.cytogfr.2020.07.002. Epub 2020 Jul 3. Cytokine Growth Factor Rev. 2020. PMID: 32694051 Review.
Pre-surgical oncolytic virotherapy improves breast cancer outcomes.
Mullins-Dansereau V, Petrazzo G, Geoffroy K, Béland D, Bourgeois-Daigneault MC. Mullins-Dansereau V, et al. Among authors: bourgeois daigneault mc. Oncoimmunology. 2019 Aug 19;8(11):e1655363. doi: 10.1080/2162402X.2019.1655363. eCollection 2019. Oncoimmunology. 2019. PMID: 31646102 Free PMC article.
Murine Tumor Models for Oncolytic Rhabdo-Virotherapy.
Falls T, Roy DG, Bell JC, Bourgeois-Daigneault MC. Falls T, et al. Among authors: bourgeois daigneault mc. ILAR J. 2016;57(1):73-85. doi: 10.1093/ilar/ilv048. ILAR J. 2016. PMID: 27034397 Free PMC article.
Tollip-induced down-regulation of MARCH1.
Bourgeois-Daigneault MC, Pezeshki AM, Galbas T, Houde M, Baril M, Früh K, Amrani A, Ishido S, Lamarre D, Thibodeau J. Bourgeois-Daigneault MC, et al. Results Immunol. 2013 Feb 20;3:17-25. doi: 10.1016/j.rinim.2013.02.002. eCollection 2013. Results Immunol. 2013. PMID: 24600555 Free PMC article.
30 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page